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Case Report
A case of myasthenia gravis with cardiac ﬁbrosis and
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Summary A 65-year-old male, who had been diagnosed to have myasthenia gravis (MG) 25
years previously, was admitted to our hospital with faintness. Cardiac ultrasonography showed
decreased left ventricular function. Magnetic resonance imaging depicted delayed contrastDelayed
gadolinium-based
contrast
enhancement;
Cardioverter-
enhancement in localized regions. No signiﬁcant coronary artery stenosis was found, and
due to the reproducible susceptibility for sustained ventricular tachycardia, he underwent
cardioverter-deﬁbrillator implantation. Although relatively uncommon, cardiac manifestations
should not be overlooked in MG patients, as they may be associated with ventricular arrhythmias
and cardiac dysfunction.
Cardeﬁbrillator
implantation
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ntroductionyasthenia gravis (MG) is an autoimmune disease with a
revalence of 400 per million, and it is characterized by
bnormal muscular fatigability caused by autoantibodies to
he nicotinic acetylcholine receptor (AChR) in the motor
nd-plates of skeletal muscles [1]. Although it is known
Published by Elsevier Ireland Ltd. All rights reserved.
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Figure 1 Gadolinium-DTPA (diethylene triamine pentaacetic acid)-enhanced magnetic resonance imaging (MRI) and endomyocar-
d MRI
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Tial biopsy specimen. (A) Apical short-axis delayed enhanced
elayed enhancement in posterior region (arrows). (B) Hemato
pecimen. Subendocardial ﬁbrosis and degeneration of cardiom
hat MG primarily affects skeletal muscle, but not cardiac
uscle, MG may be associated with various cardiac manifes-
ations; these include myocarditis, pericarditis, and cardiac
rrhythmias. In the current paper, we report a case with MG
ho presented with left ventricular dysfunction. We also
iscuss the possible underlying pathophysiological abnor-
ality that potentially causes cardiac manifestations of this
utoimmune disorder.
ase report
Japanese male was diagnosed to have MG and under-
ent thymectomy at 40 years of age. Subsequently, he
tarted corticosteroid therapy. At 65 years of age, he felt
ll, and he was admitted to a nearby hospital. Non-sustained
entricular tachycardia was documented (data not shown).
is left ventricular function was mildly reduced on cardiac
ltrasonography. Magnetic resonance imaging (MRI) showed
elayed gadolinium enhancement and local thinning of the
osterior region of the left ventricle (Figure 1A). On the
ther hand, no abnormal ﬁnding was observed by gallium-67
cintigraphy (data not shown).
He was referred to our hospital for further evalua-
ion. On admission, his blood pressure was 120/76mmHg,
nd systolic heart murmurs were auscultated at the
hird left sternal border and apex. His chest radiograph
howed cardio-thoracic ratio of 53.1%. Electrocardio-
ram at rest showed ST depression in I, aVL, and V5-6
D
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igure 2 Chest radiograph and electrocardiogram on admission
here is a slight ST segment depression in leads I, aVL, and V5-6.showed thinning of the apical posterior wall (arrowhead) and
-eosin staining and azan staining of an endomyocardial biopsy
tes are shown.
Figure 2). Bilateral ptosis and weakness of orbicularis
culi were observed. His alcohol consumption was esti-
ated to be about 360 g per week. The following data
ere obtained: leukocyte count, 7600/L; hemoglobin,
4.5 g/dL; and serum brain-type natriuretic peptide level,
07.7 pg/mL. Serum levels of blood urea nitrogen, creati-
ine, C-reactive protein, serum alpha-galactosidase activity,
ngiotensin-converting enzyme, and lysozyme were all
ithin normal ranges. Serum tested positive for anti-
ody against AChR, but negative for antibody against
yanodine receptor (RyR), as measured by a sandwich
nzyme-linked immunoassay procedure. Coronary artery
tenosis was absent on coronary angiography. An endomy-
cardial biopsy specimen in the posterior wall region of
he left ventricle, where delayed contrast-enhancement
as demonstrated by MRI, showed increased subendocardial
brosis and degenerated cardiomyocytes; however epithe-
ioid granulomatous regions were absent (Figure 1B). Left
entriculography showed an ejection fraction of 47%. Elec-
rophysiological study showed reproducible provocation of
sustained ventricular tachycardia (Figure 3); therefore,
he patient underwent implantation of a cardioverter-
eﬁbrillator.iscussion
e have described a case of an individual with MG, diag-
osed 25 years previously, with impaired left ventricular
to our hospital. (A) Chest radiograph. (B) Electrocardiogram.
MG and cardiomyopathy e43
Figure 3 Electrophysiology study. After a double extra stimulation from right ventricular apex, ventricular tachycardia was
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fprovoked (arrows). The interval between S1—S1, S1—S2, and S2—
electrocardiogram; V1, chest lead of body surface electrocardi
RVOT, right ventricular outﬂow tract; RVA, right ventricular ape
function, delayed gadolinium enhancement MRI, and easily
provoked ventricular tachycardia.
MG is an autoimmune disease caused by antibodies that
react mainly with the AChR. This autoantibody is thought
to have speciﬁc afﬁnity for the AChR in skeletal muscle,
but not in the heart muscle. Cardiac manifestations are,
in general, considered to be relatively uncommon in MG
patients; however, it has been reported that approximately
16% of MG patients have various cardiac manifestations,
such as arrhythmias and heart failure [2]. There are several
other papers reporting that histologic signs of myocardi-
tis may be observed in between 20% and 60% of all MG
cases at post-mortem examination [3]. It is also known that
cardiac involvement can be found more frequently in MG
patients with thymoma than those without thymoma. In
fact, it has been reported that 50% of MG patients with thy-
moma have cardiac involvement without obvious etiology
[2]. Autoimmune-mediated myocarditis is known to develop
especially in patients with thymoma-associated MG, and it
may underlie various cardiac manifestations. Antistriational
autoantibodies include those against 1- and 2-adrenergic
receptors, RyR, titin, and Kv1.4 [4,5]. RyR antibodies were
found to be negative in our patient, whether other autoan-
tibodies are present is under investigation.
There are autoimmunological mechanisms considered to
be participating in the cardiac involvement in MG. For
example, RyR is a calcium-channel protein located in the
sarcoplasmic reticulum membrane [1]. Although skeletal
and cardiac muscle RyRs are antigenically different, the
anti-RyR antibodies in MG patients may cross-react with
cardiac and skeletal muscle RyR [1]. Similarly, certain IgG
antibodies in MG patients may react with both 1- and 2-
adrenergic receptors [4]. Anti-titin antibodies are reported
to be associated with older-onset MG. Kv1.4 is a muscular
voltage-gated potassium channel [5]. Clinical features asso-
ciated with anti-Kv1.4 antibody-positive MG patients may
include myocarditis, QT prolongation, and thymoma [6].
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m400, 210, and 190 milliseconds. Il, lll, limb lead of body surface
m; HRA, high right atrium; HIS, His bundle electrocardiogram;
We are unable to specify the pathophysiological back-
round of cardiac manifestations in our case; however,
here are several possibilities. In our case, enhanced ﬁbrosis
n the cardiac biopsy was demonstrated; however, inﬁl-
ration of immune cells was not apparent. It has been
eported that various degrees of inﬁltration of inﬂamma-
ory cells may be observed in MG positive for antistriational
utoantibodies [5], indicating that autoimmune-mediated
ardiomyositis cannot completely be ruled out in our case.
s alcohol consumption of more than 90 g per day may
ause cardiac dysfunction [7], alcohol-induced cardiomy-
pathy may be present in our patient, who had been
onsuming about 360 g of alcohol per week. Another pos-
ibility is cardiac sarcoidosis. The ﬁndings of delayed
ontrast-enhancement in MRI [8], localized thinning of the
entricular wall, impaired left ventricular function, and
on-sustained ventricular tachycardia might also be due
o cardiac sarcoidosis. Although non-caseating epithelioid
ranuloma was not demonstrated in our case, this possi-
ility remains, because characteristic histological ﬁndings
ay be observed in fewer than 20% of cases on endomy-
cardial biopsy [9]. In addition, there is a case report
howing the coexistence of sarcoidosis and MG, although
hether this co-occurrence was just a coincidence was not
lear. Furthermore, an MG case complicated with giant cell
yocarditis after thymectomy in MG has been reported [10].
iant cell myocarditis is a rare and fatal disorder char-
cterized by rapidly progressive congestive heart failure,
nd it is sometimes associated with autoimmune disorders
uch as MG. Therefore, giant cell myocarditis should also
e considered in the case of MG with progressive heart
ailure, although our patient was less likely to be this
ase. We could not ﬁnd a paper reporting delayed gadolin-
um enhancement MRI in alcohol-induced or MG-associated
ardiomyopathy. In order to investigate the mechanisms
nderlying observed cardiac manifestations in our case, we
ay need to examine MG-related antistriational autoanti-
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odies, such as those against titin, 1- and 2-adrenergic
eceptors, and Kv1.4.
In summary, we have presented a case of a patient with
G who developed faintness and cardiac dysfunction. Car-
iac ultrasonography revealed impaired cardiac function,
nd MRI showed delayed contrast-enhancement. Although
elatively uncommon, cardiac manifestations should not be
verlooked in MG patients, as they may be associated with
entricular arrhythmias and cardiac dysfunction.
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